Associated Companies

See the links below for information on TMAC’s Associated Companies

Parexel

In early 2017, PAREXEL International, a leading global biopharmaceutical services provider, acquired TMAC. PAREXEL is focused on opportunities within commercialization, market access, regulatory, pharmacovigilance, and medical outsourcing. With TMAC, PAREXEL gains new and distinct medical affairs outsourcing capabilities that strengthen and expand its commercialization and market access offerings.

One Strategic Partnership. Many Solutions.